Pedro Fonte

Pedro Fonte is an Assistant Professor at the Faculty of Sciences and Technology, University of Algarve, and an Integrated Member of the Center for Marine Sciences (CCMAR). He also collaborates with the Institute for Bioengineering and Biosciences (iBB) at Instituto Superior Técnico, University of Lisbon. His expertise lies in nanocarriers for drug delivery, lyophilization, and structural characterization of therapeutic proteins.

Education:

• PhD in Pharmaceutical Sciences (Nanotechnologies) from the University of Porto (2016)
• MBA in Management and Business Administration from Universidade Lusíada Porto (2012)
• MSc in Pharmaceutical Sciences from Instituto Universitário de Ciências da Saúde (2010)
• BSc in Pharmaceutical Sciences from Instituto Universitário de Ciências da Saúde (2009)

Research Interests:

Dr. Fonte focuses on cutting-edge drug delivery systems, particularly nanocarriers for crossing biological barriers, lyophilization techniques for pharmaceutical stability, and protein-based therapeutics. His work addresses cancer, diabetes, and wound healing, emphasizing translational applications in nanomedicine. He has pioneered methods for stabilizing therapeutic proteins and optimizing freeze-drying parameters.

Publications:

His recent work explores lipid-based formulations, carbon dots for cancer imaging, and nanocarriers for tuberculosis. Articles highlight advancements in drug delivery, with a focus on nanotechnology’s role in overcoming biological barriers and enhancing treatment precision.

Awards:

• World's Top 2% Scientist (Stanford/Elsevier, 2023)
• Multifaceted fellowships from FCT (Portugal) supporting his doctoral and postgraduate research

Advising & Grants:

He has supervised numerous PhD and MSc students and led projects like 'NanoFreeze' and 'Uma abordagem nanotecnológica para administração tópica de insulina'. His grants total over €2M, focusing on nanomedicine and drug delivery innovations.

Labs & Teams:

He leads research teams at CCMAR and iBB, collaborating on nanocarrier development and biomaterials for medical applications. His labs emphasize interdisciplinary approaches to biopharmaceutical challenges.